United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Technology Industry News Tata Elxsi reports Rs 3,729cr FY25 revenue, eyes growth in aerospace, AI, and healthcare Tata Elxsi reports ₹3,729 crore FY25 revenue with major deal wins and aerospace foray. Find out how its AI and design strategy is fueling future growth. byPallavi MadhirajuApril 18, 2025